share_log
Breakings ·  Jun 25 20:32
Capricor Therapeutics Inc: FDA Scheduled Pre-Bla Meeting in Q3 for Deramiocel (Cap-1002)
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment